Behçet's disease associated with malignancies. Report of two cases and review of the literature

Clinical and Experimental Rheumatology

Volumn 23, Issue 4 SUPPL 38, 2005, Pages

  Kaklamani, Virginia G ^a,d   Tzonou, Anastasia ^b   Kaklamanis, Phaedon G ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ATHENS MEDICAL CENTER   (Greece)

^d NONE   (Greece)

Author keywords

Beh et's disease; Malignancies

Indexed keywords

ADENOCARCINOMA; ADULT; BEHCET DISEASE; CASE REPORT; COHORT ANALYSIS; FATALITY; FEMALE; HUMAN; KIDNEY TUMOR; LUNG TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; REVIEW; ACUTE LEUKEMIA; AGE; AGE STANDARDIZED RATE; APHTHOUS STOMATITIS; ARTICLE; BASAL CELL CANCER; BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CASE STUDY; CHRONIC MYELOID LEUKEMIA; CLINICAL ASSESSMENT TOOL; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE REDUCTION; ERYTHEMA NODOSUM; GENITAL ULCER; GREECE; HEMATOLOGIC MALIGNANCY; HISTIOCYTOSIS; HODGKIN DISEASE; HUMAN TISSUE; HYPOPYON IRITIS; IRITIS; KAPOSI SARCOMA; KIDNEY CANCER; KIDNEY CARCINOMA; LEUKEMIA; LIVER CANCER; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LYMPHOMA; LYMPHOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEOPLASM; MESENCHYMAL TUMOR; MONOTHERAPY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL APHTHOUS ULCER; OVARY CANCER; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATHERGY TEST; PHARYNX CANCER; PHEOCHROMOCYTOMA; PSEUDOFOLLICULITIS; RHABDOID TUMOR; SEMIMOMA; SMALL CELL LUNG CANCER; SMOKING; SOLID MALIGNANT NEOPLASM; STOMACH CANCER; TERATOMA; TESTIS CANCER; THYROID CANCER; TREATMENT DURATION; UTERINE ADNEXIA TERATOMA; UTERUS CANCER; UTERUS TERATOMA; UVEITIS; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADULT; BEHCET SYNDROME; COHORT STUDIES; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BUSULFAN; CARBOPLATIN; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYUREA; LEVAMISOLE; PACLITAXEL; PREDNISOLONE;

EID: 33644790729     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. KAKLAMANI VG, VAIOPOULOS G, KAKLAMANIS PH: Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
2. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. New Engl J Med 1999; 341: 1284-91.
3. ÖNDER M, GÜRER MA: The multiple faces of Behçet's disease and its aetiological factors. JEADV 2001; 15: 126-36.
4. KAKLAMANI VG, VAIOPOULOS G, MARKOMICHELAKIS N, KAKLAMANIS PH: Recurrent epididymo-orchitis in patients with Behçet's disease. J Urology 2000; 163: 487-9.
5. ZOUBOULIS CHC, KÖTTER I, DJAWARI D et al.: Adamantiades-Behçet's disease: Epidemiology in Germany and in Europe. In LEE S, BANG D, LEE E-S, SOHN S (Eds.): Behçet's Disease. A Guide to its Clinical Understanding. Textbook and Atlas. Heidelberg, New York, Springer Verlag Berlin, 2001: 157-69.
6. NISHIYAMA M, NAKAE K, YUKAWA S et al.: A study of comparison between the national epidemiological survey in 1991 and previous surveys on Behçet's disease in Japan. Environmental Health and Preventive Medicine 1999; 4: 130-4.
7. BANG D, LEE JH, LEE E-S et al.: Epidemiologic and clinical survey of Behçet's disease in Korea: The first multicenter study. J Korean Med Sci 2001; 16: 615-8.
8. GÜL A: Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19 (Suppl 24): S6-S12.
9. DIRESKENELI H: Behçet's disease: infectious aetiology; new autoantigens and HLA-B51. Ann Rheum Dis 2001; 60: 996-1002.
10. YAZICI H: The place of Behçet's syndrome among the autoimmune diseases. Intern Rev Immunol 1997; 14: 1-10.
11. YAZICI H: Behçet's syndrome: where do we stand? Am J Med 2002; 112: 75-6.
12. KOK Y, GÜLLÜ I, AKPEK G et al.: Vascular involvement in Behçet's disease. J Rheumatol 1992; 19: 402-10.
13. LIE JT: Vascular involvement in BehçAt's disease: arterial and venous and vessels of all sizes. J Rheumatol 1992; 19: 341-3.
14. EHRLICH GE: Vasculitis in Behçet's disease. Intern Rev Immunol 1997; 14: 81-8.
15. RIZZI R, BRUNO S, DAMMACCO R: Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997; 27:225-32.
16. KRAUSE I, WEINBERGER A: Vasculo-Behçet's disease. IMAJ 2002; 4: 636-7.
17. TENNIS P, ANDREWS E, BOMLARDIER C et al.: Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the province of Saskatchewan, Canada. J Clin Epidemiol 1993; 46: 685-95.
18. MORITOMO H, UEDA T, HIYAMA T, HOSONO N, MORI S, KOMATSUBARA Y: The risk of cancer in rheumatoid arthritis patients in Japan. Scand J Rheumatol 1995; 24: 157-9.
19. CARSONS S: The association of malignancy with rheumatic and connective tissue diseases. Seminars in Oncology 1997; 24: 369-72.
20. GREEN J A, DAWSON AA, WALKER W: Systemic lupus erythematosus and lymphoma. Lancet 1978; 2: 753-5.
21. LOPEZ-DUPLA M, KHAMASHTA M, PINTADO-GARCIA V, LAVILLA URIOL P, VALENCIA ORTEGA E, GIL AQUADO A: Malignancy in Aystemic lupus erythematosus: a report of five cases in a series of 96 patients. Lupus 1993; 2: 377-80.
22. MENON S, SNAITH ML, ISENBERG DA: The association of malignancy with SLE: an analysis of 150 patients under long term review. Lupus 1993; 2:177-81.
23. SELA O, SHOENFELD Y: Cancer in autoimmune diseases. Semin Arthritis Rheum 1998; 18: 77-87.
24. ABU-SHAKRA M, GUILLEMIN F, LEE P: Cancer in systemic sclerosis. Arthritis Rheum 1993; 36: 460-64.
25. MAOZ CR, LANGEVITZ P, LIVNEH A et al.: High incidence of malignancies in patients with dermatomyositis and polymyositis: An 11-year analysis. Semin Arthritis Rheum 1998; 27: 319-24.
26. HILL CL, ZHANG Y, SIGURGEIRSSON B et al.: Frequency of specific cancer types in dermatomyositis and polymyositis: A population - based study. Lancet 2001; 357: 96-100.
27. BUCHBINDER R, FORBES A, HALL S, DENNETT X, GILES G: Incidence of malignant disease in biopsy - proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001; 134: 1087-95.
28. BARNES BE: Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976; 84: 68-76.
29. BLACK KA, ZILKO PJ, DAWKINS RL, ARMSTRONG BK, MASTAGLIA GL: Cancer in connective tissue disease. Arthritis Rheum 1982; 25: 1130-3.
30. TATSIS E, REINHOLD-KELLER E, STEINDORF K, FELLER AC, GROSS WL: Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum 1999; 42: 751-6.
31. PERTUISET E, LIOTÉ F, LAUNAY-RUSS E, KEMICHE F, CERF-PAYRASTRE I, CHESNEAU A-M: Adult Hemoch-Schönlein purpura associated with malignancy. Semin Arthritis Rheum 2000; 29: 360-7.
32. HASLER P, KISTLER H, GERBER H: Vasculitides in hairy cell leukemia. Semin Arthritis Rheum 1995; 25: 134-42.
33. BANG D, LEE J-H, LEE E-S, LEE S; Ten cases of Behçet's disease associated with tumor. In BANG D, LEE E-S, LEE S (Eds.). Behçet's Disease. Design Mecca Publishing Co, 2000: 526- 8.
34. FARGE D, SAUVAGET F, ESPIE M et al.: Behçet's disease or paraneoplastic syndrome? In GODEAU P. WECHSLER B (Eds.): Behçet's disease. Elsevier Science Publ. 1993: 311-2.
35. BARNES CG: Behçet's syndrome - classification criteria. Ann Med Interne 1999; 150: 477-82.
36. http:Www.who.int/en/
37. TAGAMI H, MAKIMOTO K, YAMAZAKI M, ODERA A: A unique malignant granuloma of the pharynx. Hifuka Kiyoh 1970; 65: 253-61.
38. O' DUFFY JD, CARNEY JA, DEODHAR S: Report of 10 cases, 3 with new manifestations. Ann Intern Med 1971; 75: 561-70.
39. TAMAOKI N, HABU S, YOSHIMATSU H, TSUCHIYA M, WATANABE H, KOBAYASHI T: Thymic change in Behçet's disease. Keio J Med 1972; 21: 201-13.
40. KANEKO H, HOJO Y, NAKAJIMA H, OKAMURA A, FUKASE M, KATANO A: Behçet syndrome associated with nasal malignant lymphoma. Report of an autopsy case. Acta Path Jap 1974; 24: 141-50.
41. WIENER SL, RAI K: Hepatic friction rub. JAMA 1976; 236: 2391.
42. HUSTON KA, O' DUFFY JD, MC DUFFIE FC: Behçet's disease associated with a lymphoproliferative disorder, mixed cryoglobulinemia and an immune complex mediated vasculitis. J Rheumatol 1978; 5: 217-23.
43. MOUGEOT-MARTIN M, KRULIK M, HAROUSSEAU J-L, AUDEBERT A-A, CHAONAT Y, DEBRAY J: Leucémies aiguës survenues an décours d' une meladie de Behçet et d' une sclérose en plaques traitèes par immunosup-presseurs. Ann Méd Interne 1978; 129: 175-80.
44. OHKUMA A, TAKEUCHI J, MURAKAMI J et al.: A remission case of Ph positive acute myeloid leukemia. Rinsho Ketsueki 1982; 23: 1482-8.
45. WANG RS: A report of Behçet's syndrome complicated with acute leukemia. Clin J Hematol 1983; 4: 105.
46. INOUE S, ARAKAWA H, INOUE S et al.: A case of Behçet's disease with HC- simulating advanced gastric carcinoma. Progr Dig Endosc 1983; 23: 209.
47. SOZEN T, DUNDAR S, OTO A, OKTAY A, ARIOGUL S: Behçet's disease associated with amyloidosis. Sr J Med Sci 1984; 20: 1071-2.
48. PALMER RG, DORÉ CJ, DENMAN AM: Chlorambucil-induced chrommosome damage to human lymphocytes is dose-dependent and cumulative. Lancet 1984; I: 246-9.
49. MICHELS SD, MCKENNA RW, ARTHUR DC, BRUNNING RD: Therapy-related acute myeloid leukemia and myelodyplastic syndrome: A clinical and morphologic study of 65 cases. Blood 1985; 65: 1364-72.
50. WANG WJ, LIANG JQ: Behçet's syndrome associated with acute myeloid leukemia. Chin J Intern Med 1985; 24: 690.
51. HAMZA M'H: Cancer complicating Behçet's disease treated with chlorambucil. Ann Rheum Dis 1986; 45: 789.
52. ZHANG ZK, NAN KZ: Behçet's syndrome terminated with acute lymphoid leukemia. Chin J Intern Med 1988; 27: 195.
53. HIRAYAMA M, SAITOH T, IIDA M, TAKAHASHI Y, NAKATANI R, TAKEUCHI S: Behçet's disease terminating in multiple myeloma. A case report. Dohnan Igaku Zasshi 1988; 23: 171.
54. MAKAEWA I, KAWAMURA S, MIYAKE T: Acute non-lymphocytic leukemia complicating with Behçet's disease - report of two autopsied cases. Asahikawa Shibyoshi 1988; 20: 49.
55. NEHASHI Y, TORII Y, YAGUCHI M, HTEX Y, OHYASHIKI K, TOYAMA K: Incomplete form of Behçet's disease in a case of monopathic myelodysplastic syndrome presenting as thrombocytopenia. Jpn J Clin Hematol 1988; 29: 1097-102.
56. KAMATA T, YAMAGUTI A, FUSIDA S et al.: A case report of the development of intestinal Behçet's disease immediately after sigmoidoscopy for sigmoid cancer. Nippon Shokakigeka Gakkai Zasshi 1988; 21: 2331.
57. MURATA I, OMAGARI K, NISHIHATA S et al.: A case of Behçet disease associated with hepatocellular carcinoma. Gan No Rinsho 1989; 35: 625-31.
58. OISHI S, KOGA B, SASAKI M, UMEDA T, SATO T: Pheochromocytoma associated with Behçet's disease. Jpn J Clin Oncol 1989; 19: 283-6.
59. NAKAYAMA S, ISHIKAWA T, YABE H, NAAGAI K: Refractory anemia complicated by Behçet's disease - Report of three cases. Jpn J clin Hematol 1989; 30: 530-4.
60. MOULONGUET-MICHAU I, BLANC F, CAVELIER-BALLOY, BRICE P, FLAGEUL B, CIVATTE J: Lymphome angiocentique au cours d'une maladie de Behçet. Ann Dermatol Venereol 1990; 117: 885-7.
61. AOI K, OYAMA T, ISHIBE et al.: Early cancer of the rectum in a patient with Behçet's disease treated by endoscopic polypectomy. Hiroshima Igaku 1990; 43: 992-5.
62. DONG Y, ZHANG NZ: Behçet's syndrome and malignancy: A report of six cases. In O' DUFFY JD, KOKMEN E (Eds.): Behçet's disease. Basic and clinical aspects. Marcel Dekker Inc. New York, 1991: 253-8.
63. TAKISHITA N, HORIUCHI T, HATO T, FUJITA S, KOBAYASHI Y: Myelodysplastic syndrome complicated with Behçet's disease. Ehime Igaku 1991; 11: 39-43.
64. DOMINGO-ALBOS A, BARNADAS MA, BRUNET S et al.: Behçet's disease associated with chronic grannlocytic leukemia treated with allogenic bane narrow transplantation. In O' DUFFY JD, KOKMEN E. (Eds): Behçet's Disease. Basic and Clinical Aspects. Marcel Dekker Inc New York, 1991; p. 309-12.
65. KÖTTER I, AEPINUS C, GRAEPLER F et al.: HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha. Ann Rheum Dis 2001; 60: 83-6.
66. CHYUMA Y, UTSUNOMIYA A, SAITO T, HANADA S, NISHIMATA H, ARIMA T: Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome. Jpn J Clin Hematol 1992; 33: 333-7.
67. MOLINA M, AQUAYO JL, ORTEGA G, DE PACO M, CUESTA F, AGUDO MD: Ulceras digestivas inespecifical j enfermedad de Behçet. An Med Intern (Madrid) 1992; 9: 237-8.
68. KAWAMOTO S, TERADA H, NIIKURA H, KUMASAKA T, SAIKI S: Hodgkin's disease associated with Behçet's disease. Jpn J Clin Hematol 1992; 33: 211-5.
69. YOSHIZAWA Y, HIRAI A, IZAKI S, KITAMURA K: Behçet's disease associated with myelodysplastic disorder. Hifu Rinsho 1992; 34: 1585-9.
70. HARADA K, OHTSURU K, NAKAYAMA K, TAKAGI S, SUGITA Y, TORIGOE R: Intracranial primary malignant lymphoma following Behçet's disease - case report. No to Shinkei 1992; 44: 1029-33
71. LOUZIR B, OTHMANI S, GRITLI N et al.: Erythroleucékemie cher un patient ayant une maladie de Behçet et traité au long cours par thalidomide. Ann Med Interne 1992; 143: 479-80.
72. TASSIES D, CERVANTES F, FELIU E et al.: Enfemedad de Behçet de inicio previo a la aparición de leukemia mieloide crónica. Med Clin (Barc) 1992; 99: 67-8..
73. BAYRAKTAR Y, UZUMELIMOGLU B, ERYILMAZ et al.: Hepatocellular carcinoma in Behçet patients complicated with hepatic veins and inferior vena caval involvements. In GODEAU P, WECHSELER B (Eds.): Behçet's disease. Elsevier Science Publ. 1993: 551-6.
74. ABE T, YACHI A, YABANA T et al.: Gastic non-Hodgkin's lymphoma associated with Behçet's disease. Internal Medicine 1993; 32: 663-7.
75. KAGEYAMA H. HIDAHA T. KONDOU S, TAMURA K: Intestinal Behçet's disease associated with myelodysplastic syndrome. Jpn J Clin Hematol 1993; 34: 1288.
76. SEGAWA F, SHIMIZU Y, SAITO E, KINOSHITA M: Behçet's disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol 1995; 22: 1183-4.
77. YANO K, EGUCHI K, MIGITA K et al.: Behçet's disease complicating with myelodysplastic syndrome. A report of two cases and review of the literature. Clin Rheumatol 1996; 15: 91-3.
78. YAMAMOTO T, TAMURA M, HAMAUZU T et al.: Intestinal Behçet's disease associated with non-Hodgkin's lymphoma. J Gastroenterol 1997; 32: 241-5.
79. OHNO E, OHTSUKA E, WATANABE K et al.: Behçet's disease associated with myelodysplastic syndromes. A case report and a review of the literature. Cancer 1997; 79: 262-8.
80. BUDAK-ALPDOGAN T, DEMIRÇAY Z, ALPDOGAN Ö et al.: Behçet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alfa treatment in the occurrence of Behçet's symptoms. Ann Hematol 1997; 74: 45-8.
81. KALOTERAKIS A, STAVRIANEAS NG, KARAGIANNI IN et al.: Adamantiades - Behçet's disease coexisting with acute myloblastic leukemia. Brit J Dermatol 1997; 137: 317-8.
82. MURAMATSU M, KOTAKE S, YOSHIKAWA K, SASAMOTO Y, MATSUDA H, YAMAWAKI S: The development of malignant rhabdoid tumor in a patient with Behçet's disease treated with ciclosporin. Graefe's Arch Clin Exp Ophthalmol 1998; 236: 798-9.
83. DELLA ROSSA A, TAVONI A, TOGNETTI A, TESTI C, BOMBARDIERI S: Behçet's disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism. Clin Rheumatol 1998; 17: 515-7.
84. BANGESTER M, GRIESSHAMMER M, TIRPITZ CV et al.: Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease. Scand J Rheumatol 1999; 28: 117-9.
85. CELIK I, ALTUNDAG K, ERMAN M, BALTALI E: Cyclophosphamide - associated carcinoma of the urinary bladder in Behçet's disease. Nephron 1999; 81: 239.
86. BETHEA L, KHAN S: Behçet's disease and pheochromocytoma. J South Carol Med Assoc 1999; 95: 295-8.
87. SHAHRAM F, DANESHMANDI S, BAYAN N, NADJI A, AKBARIAN M, DAVATCHI F: Behçet's disease and malignancy, report of 11 cases. In BANG D, LEE E-S, LEE S (Eds.): Behçet's disease. Design Mecca publishing Co, 2000: 515-9.
88. AKPOLAT T, YILDIZ L, AKPOLAT I, SELCUK MB, OZBEK N, YÜCEL I: Small - cell carcinoma as a cause of superior vena cava syndrome in a patient with Behçet's disease. Respiration 2000; 67: 593.
89. GÜNAYDIN I, WAGNER D, MOHREN M, DAIKELER T, BERG C, JEDRYCHOWSKI A: Myelodysplastic syndrome associated with Behçet's disease. In BANG D. LEE E-S, LEE S (Eds.): Behçet's disease. Design Mecca publishing Co. 2000: 957.
90. VAIOPOULOS G, TERPOS E, VINIOU N, NODAROS K, ROMBOS J, LOUKOPOULOS D: Behçet's disease in a patient with chronic myelogenous leukemia under Hydroxyurea treatment: A case report and review of the literature. Am J Hematol 2000; 66:31-2.
91. KARUVANNUR S, LIPSTEIN E, BRENNESSEL D, ROSNER F: Atypical Behçet's syndrome in a patient with myelodysplastic syndrome. Mount Sinai J Med 2001; 68: 403-5.
92. CENGIZ M, ALTUNDAG MK, ZORLU AF, GÜLLÜ IH, ÖZYAR E, ATAHAN IL: Malignancy in Behçet's disease: A report of 13 cases and a review of the literature: Clin Rheumatol 2001; 20: 239-44.
93. HOUMAN MH, BEN GHORBEL I, B'CHIRHAMZAOUI S, LAMLOUM M, KCHIR N, MILED M: Lymphome intestinal associe a une maladie de Behçet. Ann Med Interne 2001; 152: 415-8.
94. KURAL-SEYAHI E, FRESCO I, SEYAHI N et al.: The long-term mortality and morbidity of Behçet's syndrome. A 2-decane outcome survey of 387 patients followed at a dedicated center. Medicine 2003; 82: 60-76.
95. ÇELIK K, BATISTA I, TEKUZMAN G, KANSU E, KIRAZ S. CALGÜNERI M: Behçet's Aisease: advantageous against development of neoplasia? Ann Rheum Dis 1996; 55: 648.
96. HORIIKE S, TANIWAKI M, MISAWA S, ABE T: Chromosome abnormalities and karyotypic evolution in 83 patients with myeolodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129-38.
97. JACOBS RH, CORNBLEET MA, VARDIMAN JW, LARSON RA, LE BEAN MN, ROWLEY JD: Prognostic implications of morphogy and karyotype in primarily myelodysplastic syndromes. Blood 1986; 67: 1765-72.
98. LEHNER TH: Immunopathogenesis of Behçet's disease. Ann Med Interne 1999; 150: 483-7.
99. KAKLAMANI VG, KAKLAMANIS PH: Treatment of Behçet's disease - An update. Semin Arthritis Rheum 2001; 30: 299-312.